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BACKGROUND
Guidelines on physical activity or exercise and
pregnancy encourage pregnant women to continue
or adopt an active lifestyle during and following
pregnancy.1–3 Two systematic reviews of
pregnancy-related guidelines on physical activity
found similarities between recommendations from
different countries, but noted that the guidelines
differed in focus.4 5 The guidelines provided vari-
able guidance on prenatal exercise, or on how preg-
nant women might approach continuing or
adopting sport activities.6 However, most guide-
lines did not include important topics such as
prevalence and known risk factors for common
pregnancy-related diseases and complaints, and the
role of exercise in preventing and treating them.
Importantly, the focus of most previous guide-
lines has been on healthy pregnant women in the
general population, in whom there is almost always
a decline in physical activity during pregnancy.7 8
Indeed, a high proportion of pregnant women
follow neither physical activity nor exercise guide-
lines,9 putting them at increased risk of obesity, ges-
tational diabetes mellitus (GDM), and other
pregnancy-related diseases and complaints.1
On the other hand, there are enthusiastic exerci-
sers and elite athletes who often meet and exceed
general exercise recommendations for pregnant
women, but there are no exercise guidelines specif-
ically for these women. Important questions for
such women are unanswered in current guidelines:
Which activities, exercises and sports can they
perform, for how long and at what intensity,
without risking their own health and the health of
the fetus? How soon can they return to high-
intensity training and competition after childbirth?
The IOC and most National Sports Federations
encourage women to participate in all Olympic
sport disciplines. The IOC promotes high-level per-
formance, and it is also strongly committed to pro-
moting lifelong health among athletes10—not just
during their competitive sporting careers. With an
increasing number of elite female athletes compet-
ing well into their thirties, many may wish to
become pregnant, and some also want to continue
to compete after childbirth. With this background,
the IOC assembled an international expert commit-
tee to review the literature on physical activity and
exercise (1) during pregnancy and (2) after child-
birth, using rigorous systematic review and search
criteria.11 For efficiency, where sex is not specified,
the reader should assume that this manuscript
about pregnancy and childbirth refers to females
(ie, ‘the elite athlete who wishes to train at altitude’
is used in preference to ‘the elite female athlete…’).
AIMS
The September 2015 IOC meeting of 16 experts in
Lausanne had three aims. They were to:
1. Summarise common conditions, illnesses and
complaints that may interfere with strenuous
exercise and competition, during pregnancy and
after childbirth;
2. Provide recommendations for exercise training
during pregnancy and after childbirth, for high-
level regular exercisers and elite athletes; and
3. Identify major gaps in the literature that limit
the confidence with which recommendations
can be made.
METHODS
For each section of the document, a search strategy
was performed using search terms such as ‘pregnancy’
OR ‘pregnant’ OR ‘postpartum’ AND ‘exercise’ OR
‘physical activity’OR ‘leisure activity’OR ‘leisure’OR
‘recreation’ OR ‘recreational activity’ or ‘physical
fitness’ OR ‘occupational activity’ AND terms related
to the condition under study (eg, ‘gestational dia-
betes’). Available databases were searched, with an
emphasis on PubMed, EMBASE, Cochrane, PEDro,
Web of Science and SPORTDiscus. In addition, exist-
ing guidelines with reference lists were scanned.
The review of each topic followed the general
order: prevalence of the condition in the general
pregnant or postpartum population, prevalence in
high-level exercisers or elite athletes, risk factors in
the general population and in relation to exercise
and sport, and effect of preventive and treatment
interventions. Level of evidence and grade of recom-
mendations are according to the Cochrane hand-
book (table 1) for prevention and treatment
interventions only.
Each member of the working group was assigned to be the
lead author of one or more topics and 1–3 others were assigned
to review each topic. A first full consensus draft was reviewed
before and during the 3-day IOC meeting (27–29 September
2015), and a new version of each topic was submitted to the
meeting chairs (KB and KMK) shortly after the meeting. Each
topic leader made amendments before sending a new version
for comments to the working group.
DEFINITIONS
Terms used in this review:12
PRECONCEPTION: APPLYING CURRENT KNOWLEDGE TO
THE CARE OF THE ELITE ATHLETE
The goal of preconception care is to optimise the woman’s
health and knowledge before planning, and conceiving a preg-
nancy and thus reduce the risk of adverse health effects for the
woman, fetus or neonate. Because reproductive capacity spans
almost four decades, optimising women’s health before and
between pregnancies is an ongoing process that requires access
to, and the full participation of, all segments of the healthcare
system.13
Preconception care aims to identify and modify biomedical,
behavioural and social risks through preventive management
intervention.14 The American Academy of Paediatricians and
the American College of Obstetrics and Gynaecology classify
this care into four categories:13 physical assessment, risk
assessment, vaccinations and counselling. For the elite athlete, a
number of particular areas should be highlighted and addressed.
Increasing age is associated with decreased fertility15 and
increased rates of chromosomal abnormalities.16
To optimise fertility without in vitro fertilisation (IVF), one
research group recommends that couples should start attempting
conception at no later than 32 years of age if they are planning
a one-child family, 27 years for a two-child family or 23 years
for three children. If couples accept a 75% or lower chance of
family completion, they can start 4–11 years later. If IVF is an
option, couples can delay trying to conceive until the female
partner is 35 years of age or younger for a one-child family, or
until 31 years for two children, or 28 years for three children.17
This age period coincides with peak performance for many ath-
letes, who may have impaired fertility related to relative energy
deficiency in sport (RED-S),18–21 a consideration when making
reproductive health recommendations to athletes. RED-S refers to
impaired physiological function including, but not limited to,
metabolic rate, menstrual function, bone health, protein synthesis,
immunological health and cardiovascular health caused by relative
energy deficiency.18 The long-term reproductive repercussions of
RED-S for women are unknown and further research is
required.18 Numerous features of RED-S have a negative impact
on fertility. These include disordered eating and the associated
hormonal imbalance. The reader interested in this topic is referred
to the IOC Consensus Statement on RED-S.18–21
Eating disorders, pregnancy and athletes
There is consistent evidence that the frequency of eating
disorders is higher among athletes (20–22%) than non-athletes
(3–9%), with an especially high prevalence in weight-sensitive
sports such as endurance (24%), aesthetic (42%) and sports
with weight (30%) categories.22–25 Competitive athletes are
constantly under the stress of improving their results and adapt-
ing to the sport-specific ‘ideal’. Important risk factors for severe
eating disorders include pressure to lose weight, the early start
of sport-specific training, overtraining, injuries, restriction of
food intake and individual vulnerability.22 25 In addition, the
sport environment and inappropriate coaching behaviour can
exacerbate the issue.25 Those with a severe eating disorder are
at risk for both medical complications and death, with a
reported mortality rate between 4% and 10%.26
Pregnant athletes with an eating disorder, and their offspring,
are at particular risk as they compete for limited nutritional
resources. To our knowledge, there are no data on prevalence of
eating disorders in pregnant athletes.
Complications associated with eating disorders
Pregnancy complications for women with anorexia nervosa
include hyperemesis gravidarum, anaemia, spontaneous abor-
tion, preterm birth (PTB), caesarean section, and postpartum
Physical activity Any bodily movement produced by the skeletal
muscles that results in a substantial increase over
resting energy expenditure.
Exercise Physical activity that is usually performed on a
repeated basis over an extended period of time
(exercise training) with a specific external objective
such as improvement of fitness, physical performance
or health.
Mode Type of exercise (running, swimming, etc) AND
temporal pattern of activity (continuous or
intermittent activity).
Intensity Absolute or relative (eg, percentage of one repetition
maximum or maximum oxygen consumption: VO2max/
heart rate (HR) reserve).
Frequency Number of sessions undertaken in a typical week.
Duration Minutes or hours of one session or the whole exercise
period (3 months, 1 year).




Those components of fitness that are necessary for
optimal work or sport performance; the individual’s
ability in athletic competition, performance or
occupational work.
Health-related fitness A state characterised by (1) an ability to perform daily
activities with vigour and (2) demonstration of traits
and capacities that are associated with low risk of
premature development of hypokinetic diseases and
conditions.
Exerciser A person who performs regular strenuous exercise
both for fitness and competition, but not representing
any national team.
Elite athlete A person who is a member of any national team or
other high-level representative team in any sport
organised by a National Sports Federation.
Postpartum In general, the period from childbirth until 6 weeks
postpartum. For this review, we have extended this
period to 12 months after childbirth.





Randomised trials; or double-upgraded observational studies High
Downgraded randomised trials; or upgraded observational
studies
Moderate
Double-downgraded randomised trials; or observational studies Low
Triple-downgraded randomised trials; or downgraded
observational studies; or case series/case reports
Very low
depression.27–29 In addition, the neonate is at risk for low birth
weight (LBW) and small head.30 31 Some studies have shown
that these infants have developmental disturbances that persist
throughout childhood and adulthood compared with children
born to mothers without eating disorders.31 32 These children
are also more prone to develop anxiety, depression and sub-
stance abuse.27 32
Pregnancy complications associated with bulimia nervosa are
similar to those reported with anorexia nervosa. Additional
complications include increased risk of vaginal bleeding, hyper-
tension, fetal abnormalities, low Apgar scores, breech delivery
and stillbirth.27 33
Management and treatment
If a pregnant athlete were to have symptoms of, or be consid-
ered at risk for, abnormal eating behaviour by medical staff,
coaches or other off-field team members, the first step would be
to refer appropriately (eg, to a nutritionist or psychiatrist, if
appropriate). Close follow up by a team of nutrition, maternal-
fetal medicine and psychiatric specialists is required to optimise
maternal and fetal outcomes.27 34 In severe cases, management
may require hospitalisation.
Conclusion
The pregnant athlete with a past or current eating disorder
should be considered as being at higher risk of pregnancy com-
plications and requires close monitoring by hypertension, mis-
carriage, difficult labour, premature delivery and intrauterine
growth restriction. Hence, they should be monitored closely,
including involvement of a multidisciplinary team, emphasising
early recognition and treatment of symptoms, meal planning,
training regimen adjustments, and evaluation for maternal or
fetal consequences of malnutrition.
PREGNANCY
Anatomical and physiological adaptations to pregnancy
during each trimester
During pregnancy, there are major changes in the body’s physi-
ology and morphology. In this section, we highlight how regular
or intense exercise influences the pregnancy-related changes. For
a comprehensive overview of the physiology of normal preg-
nancy, unrelated to exercise and sport, we recommend
references.35 36
Musculoskeletal adaptations to pregnancy
The expanding uterus displaces the centre of gravity, which
results in the woman compensating to avoid falling forward.
This may result in progressive lumbar lordosis and anterior rota-
tion of the pelvis on the femur,37 though this finding is not uni-
formly observed.38 If there is an increase in lordosis, then an
increase in anterior flexion of the cervical spine and abduction
of the shoulders also takes place, which may interfere with per-
formance in specific sports. Enlarged breasts also contribute to
the shift in the centre of gravity.
During late pregnancy and the early postpartum period, most
often there are significant decreases in both the length of the
gait cycle and step length,39–43 and a significant increase in
double support time.40 41 44 Additionally, single support time is
reduced41 44 and step width increased leading to a wider
stance.42 45
During pregnancy, the anterior tilt of the pelvis increases by
approximately 5°,39 44 followed with an increase in hip flexion
during stance phase,39 40 an increase of knee flexion during the
terminal stance phase,41 a decrease of knee extension,40 and a
decrease of ankle dorsiflexion and plantar flexion.39 40
Our search revealed no studies on biomechanical changes in
regular exercisers or in elite athletes.
How muscle changes with pregnancy
There are few studies on the muscle morphology of pregnant
women. Changes in hormone receptors and their regulators
may promote changes in skeletal muscle fibre type (from oxida-
tive to glycolytic).46
How balance changes with pregnancy
Postural balance is affected after the first trimester of preg-
nancy.47 Subsequently, falling is a common cause of injury in the
general pregnant population, and pregnant women are 2–3
times more likely to be injured by falling than are non-pregnant
women.47 48 Physical activity and exercise may mitigate this
risk, but this has not been tested in the research setting.
Cardiorespiratory, metabolic and thermoregulatory
adaptations to pregnancy
Hormones and growth factors are released into the maternal
system in early pregnancy by the corpus luteum, placenta and
developing embryo.49 These trigger a cascade of physiological
events that regulate implantation and fetal–placental growth and
development,50 leading to maternal, placental and fetal adapta-
tions that occur in a normal low-risk pregnancy.
Cardiorespiratory adaptations to pregnancy
From about the fifth week of gestation, pregnancy induces
rapid, progressive and substantial alterations to the cardiovascu-
lar system,51 which ensure blood supply to the fetus.52
Oestrogen-mediated remodelling reduces vascular tone, leading
to a primary reduction in afterload and an increase in venous
capacitance.51 This is reflected in increased resting cardiac
output of about 50% over non-pregnant values.53
Remodelling of the heart increases the dimensions of the ven-
tricular cavity54 without increasing wall thickness,55 increases
aortic capacitance56 and reduces peripheral vascular resistance.57
There is a 15–20 bpm increase in resting HR over non-pregnant
values.58 Stroke volume also increases by approximately 10% by
the end of the first trimester.59 This manifests before significant
enhancement in maternal blood volume,51 which may increase
up to 50% above pre-pregnancy values by late pregnancy.60 61
There are also pregnancy-induced adaptations to the maternal
respiratory system. For example, remodelling and expansion of
the thoracic cage raises diaphragmatic mid-position;62 this
decreases residual volume and expiratory reserve volume.63 One
of the most substantial physiological pregnancy-induced
changes, possibly designed to protect against fetal acidosis,64 is
an increase in respiratory sensitivity to carbon dioxide (CO2)
early in pregnancy. This increases tidal volume and minute ven-
tilation, which reduces arterial carbon dioxide tension and
increases arterial oxygen tension.65 These changes create a
buffer that protects the fetus from any acute elevations in mater-
nal carbon dioxide levels.66
Many pregnant women complain of respiratory discomfort
(dyspnoea), especially in late pregnancy, both at rest and after
exertion.67 Resting oxygen uptake (relative–mL/kg/min) reflects
the increase in body mass during pregnancy, and thus declines
slightly during each trimester.35 However, during submaximal
steady-state exercise, pregnant women’s perceptions of respira-
tory effort and dyspnoea seem to be reduced,68 because mater-
nal anatomical and mechanical respiratory adaptations reduce
airway resistance, preserve breathing mechanics, minimise the
effort of ventilation and thus increase minute ventilation.69
Effect of posture on maternal and fetal cardiovascular
dynamics
Supine posture leads to compression of the inferior vena cava
by the pregnant uterus, which, in turn, decreases stroke volume,
end-diastolic volume index and left ventricular ejection time,
with decelerations in maternal HR.70 Being motionless (includ-
ing standing and certain yoga positions) or exercising in the
supine position, may decrease venous return and cause hypoten-
sion in 10–20% of pregnant women.70–72 One small study has
reported that although uterine blood flow also decreased during
supine exercise, this decrease was half that seen during supine
rest. If symptomatic, women should avoid the supine position.72
There are no studies on the effect of exercise in the supine pos-
ition during pregnancy in elite athletes.
Metabolic adaptations in a normal pregnancy
The major energy substrate for growth of the fetoplacental unit
is maternal blood glucose, and thus maternal metabolism adapts
to supply adequate glucose.73 A cascade of hormonal events
increases maternal blood glucose, decreases liver glycogen
storage, elevates liver glucose release74 and increases maternal
insulin levels.75 This increases insulin resistance in skeletal
muscle76 and thus decreases maternal utilisation of glucose in
peripheral tissues, which leaves more maternal glucose for fetal
use.77 The fetoplacental unit can use as much as 30–50% of the
maternal glucose pool in late gestation.78
Changes in responsiveness of the maternal pancreatic β-cell
that lead to insulin resistance occur in concert with growth of
the fetoplacental unit, as hormones such as human placental lac-
togen, progesterone, cortisol and prolactin are released.79 Early
in pregnancy, maternal body fat is stored, due to the lipogenic
action of higher maternal insulin concentrations.80 These
adipose stores may provide an alternative energy source for the
mother later in pregnancy, and preserve maternal blood glucose
for fetal use.81
Thermoregulatory adaptations to pregnancy
The fetal neural tube is formed 35–42 days from the last men-
strual period, and therefore exposure to increases in tempera-
ture after this time should not affect the risk of neural tube
defects.82
During neural tube development, raising body core tempera-
ture above 103°F (39°C) can increase the risk of fetal (neural
tube defect) abnormalities. Exercising in pregnancy at 60–70%
of VO2max in a controlled environment for up to 60 min does
not raise core temperature above 38°C.83 Higher body core tem-
perature could be reached during strenuous exercise, such as
marathon running, or exercising outdoors in hot and humid
weather. However, this has not be evaluated in elite pregnant
athletes.
Thermoregulation steadily improves during pregnancy, as
reflected by a gradual decline in rectal temperature.84 85 As
pregnancy advances, a downward shift in body temperature
threshold initiates sweating, resulting in evaporative heat loss
starting at a lower body temperature.84 The improved heat dissi-
pation at rest may be due to decreased vascular tone, with
increased circulation to the skin,86 augmentation of minute ven-
tilation and plasma volume expansion.84 Maternal heat dissipa-
tion is vital because fetal metabolism generates heat, and fetal
temperature depends on maternal temperature, fetal metabolism
and uterine blood flow85 (figure 1).
Nutritional requirements for normal pregnancy
Pregnancy increases a woman’s requirements for energy, many
nutrients and fluid. This permits growth and development of
the fetus and deposition of maternal tissue stores.87 Additional
energy is needed specifically for development of the fetus, pla-
centa, amniotic fluid, uterus, breasts, adipose tissue, and the
increased volumes of blood and extracellular fluid.87 The add-
itional energy need for pregnant women with a mean GWG of
12 kg is estimated to be:
▸ 325 MJ (77 700 kcal) in total and 375 kJ/day (90 kcal/day)
for the first trimester,
▸ 1200 kJ/day (287 kcal/day) for the second trimester, and
▸ 1950 kJ/day (466 kcal/day) for the third trimester of
pregnancy.88
Energy expenditure is likely to remain high among pregnant
elite athletes who continue to train during pregnancy and the
total energy intake required will depend on the type, frequency,
intensity and duration of the activities performed. An exercising
woman can monitor whether she has appropriate energy intake
by comparing her weight gain and body mass index (BMI) with
the Institute of Medicine (IOM) recommendations (table 2).89
Endurance (including altitude), resistance and flexibility
training during pregnancy
Exercise training in pregnant women is influenced by the
physiological changes described in the preceding sections.
Broadly speaking, women with low-risk pregnancies can under-
take the major types of training while pregnant.
Endurance
Among recreational athletes, there were no differences in
aerobic fitness (absolute VO2max) tested during the past
2 months of a singleton pregnancy and again 6–8 weeks post-
partum.90 In more highly conditioned athletes, a
moderate-to-high level of exercise during and after pregnancy
may lead to an increase in VO2max in the region of 5–10% after
pregnancy.90 91 Improved anaerobic working capacity is also
better preserved in fitter subjects.92 Taken together, these studies
indicate that a woman’s aerobic fitness will stay the same or
improve slightly during pregnancy if she continues to exercise as
her maternal symptoms permit.
Measuring performance during pregnancy: testing VO2max,
submaximal tests and HR monitoring
Three standard tests of near maximum exercise capacity (ie, (1)
peak VO2 test, (2) true VO2max test
83 93–95 and (3) tests ending
at volitional fatigue)96–100 exist. Harmful events have been
Table 2 Recommendations for total weight gain range in













range in the second
and third trimester,
lbs (kg)
<18.5 Underweight 28–40 12.5–18.0 1.0–1.3 (0.44–0.58)
18.5–24.9 Normal
weight
25–35 11.5–16.0 0.8–1.0 (0.35–0.50)
25.0–29.9 Overweight 15–25 7.0–11.5 0.5–0.7 (0.23–0.33)
>30.0* Obese 11–20 5.0–9.0 0.4–0.6 (0.17–0.27)
*Includes class I (30-34.9), II (35-39.9) and III (>40).
reported for neither mother nor fetus after these tests.
However, it is not ethical to test pregnant women to ‘failure’.
Studies show transient fetal bradycardia when the pregnant elite
athlete exercises at above 90% of maximal maternal HR,101–103
but whether these transient fetal HR changes influence neonatal
outcomes is unknown. To be appropriately cautious, maximal
VO2 testing and exercise above 90% of VO2 max is not recom-
mended, except in highly supervised (research) settings.
An alternative to VO2max testing during pregnancy is to predict
target HRs for training from VO2peak tests
100 or to
predict VO2max from submaximal testing.
104–106 Target HR
ranges do exist—based on age—that were calculated from fit
women at 16–20 weeks of pregnancy who had a VO2 peak of
>27.2 mL/kg/min (women aged 20–29 years) and >26.1 mL/
kg/min (women aged 30–39 years). The target HR ranges were
based on 60–80% of measured VO2 peak values and are listed
as 145–160 bpm (women aged 20–29 years) and 140–156 bpm
(women aged 30–39 years).100 Given the range of sports in
which pregnant elite athletes participate, if desired, these target
HRs should be calculated on an individual basis.
Testing with ventilatory analyses (eg, expiratory volume/VO2)
is often used to determine target zones for distance and interval
training in elite athletes,107 and could provide pregnant women
with an alternative form of submaximal exercise testing. If an
elite athlete wished to continue training based on ventilatory
threshold test results, she can be assured that during mild or
moderate exercise the RER (respiratory exchange) is not signifi-
cantly different in pregnant women than in non-pregnant
women.108
During strenuous exercise, the RER rate is lower for the preg-
nant woman.81 Pregnancy is associated with a mild alkalosis, by
increasing respiration at a given metabolic rate.66 The increased
respiration causes the woman to expire more CO2 than normal.
This makes the RER increase towards 1.0, which, in the non-
pregnant athlete, suggests use of carbohydrate stores. However,
in the pregnant athlete, this response is not related specifically
to metabolism, and this may limit the use of RER to determine
substrate and training zones for more intense exercise in preg-
nant women.109 110
Borg scale
During pregnancy, Borg’s ratings of perceived exertion (RPE)
scale does not correlate strongly with HR.111 HR predicted
from RPE is significantly underestimated in the second trimester
during walking (ie, actual mean HR is greater than predicted
HR by 16 bpm), aerobics classes (15 bpm) and circuit training
(18 bpm). In the third trimester, HR while cycling and during
aerobics classes are underestimated by a mean of 16 and
11 bpm, respectively, but maximal individual HR underestima-
tions may be up to 54 bpm.111 A woman who uses RPE as a
guide may be exercising at a much higher HR than her RPE
would suggest. If an elite athlete is trying to keep her HR
within a ‘safe’ range, RPE should not be used as the only
measure of exercise intensity, particularly from the second tri-
mester. The athlete should measure HR directly.
Intensity of endurance training during pregnancy
Recent studies have shown that most recreational and competi-
tive runners voluntarily reduce their training volume during
pregnancy and fewer than one-third continue to run during the
third trimester.112 If a woman runs in the third trimester, the
intensity of her run is generally reduced.112
Endurance training produces measurable fitness improvement
in pregnant women. VO2peak is higher in fit pregnant women
Figure 1 Flow chart of maternal,
placental and fetal adaptations that
occur in a low-risk pregnancy to
protect the fetus from potential risks of
maternal exercise. The solid arrows
represent potential effects of maternal
exercise. The dashed arrows represent
fetal, placental and maternal
adaptations that occur in a low-risk
pregnancy to counterbalance these
potential maternal exercise effects
(adapted with permission from
Mottola35).
(>27.2 and >26.1 mL/kg/min for ages 20–29 and 30–39 years,
respectively), than in unfit non-pregnant women (<21.0 and
<19.6 mL/kg/min, respectively).100 Athletes of national and
international calibre, but representing a range of different sports
including rhythmic gymnastics (which is not an endurance
sport), had a VO2max range of 38.5–52.6 mL/kg/min at 15–19
weeks of gestation, while maintaining up to 8.4 h/week of vigor-
ous high-volume exercise.91 These findings cannot, however, be
directly compared with those of today’s non-pregnant female
endurance athletes, many of whom have VO2max in the range of
68–76 mL/kg/min.113
Exercise at altitude during pregnancy
Elite endurance athletes regularly train at altitude. Whether the
pregnant athlete will (1) benefit from this and (2) not comprom-
ise her health or that of the fetus is based on isolated observa-
tions and a handful of studies. No study has explored the limits
of combined exercise and altitude exposure in pregnancy.114
To test the level of fetal tolerance and responses to an oxygen
reduced environment, symptom-limited VO2max exercise
tests were conducted in seven healthy pregnant women at
33–34 weeks gestation at sea level, and within a week, also at an
altitude of 6000 feet, after a rapid ascent. Although the low-
lander participants had some limitations to maximal aerobic
capacity, there were no ominous fetal responses.115 There are no
studies on pregnant endurance elite athletes exercising at high
altitudes (cross-country skiers and runners). The theoretical
concern about training at altitude while pregnant is that hypoxia
and exercise both decrease blood flow to the uterus, and thus
contribute to a decrease in fetal arterial oxygen saturation.
Thus, while acknowledging the lack of data, it seems advisable
to refrain from high-intensity training regimes at altitudes
greater than 1500–2000 m.116
Strength training
Light-to-moderate weight training with free weights or weight
machines generally has no adverse health effects during preg-
nancy.71 117–119 Large strength gains have been reported in
apparently healthy pregnant women who adopted strength
training twice per week for 12 weeks during pregnancy (36%
for leg press, 39% for leg curl, 39% for lat pull down, 41% for
lumbar extension and 56% for leg extension). Training was
associated with a 14% increase in lumbar endurance.120
However, the training doses used in those studies are not
comparable to the strenuous weight training performed by some
elite athletes. Women who are considering heavy strength train-
ing in pregnancy should understand that the Valsalva manoeuvre
used during weight training precipitates a rapid increase in
blood pressure and intra-abdominal pressure, and therefore may
temporarily decrease blood flow to the fetus.37 121 122 The
repercussions to the fetus of these temporary changes remain
unknown. In addition, those athletes participating in heavy
strength training should acknowledge that large increases in
intra-abdominal pressure may harm the pelvic floor support,
which may increase the risk of urinary (UI) or anal incontinence
(AI) or pelvic organ prolapse (POP) during or after preg-
nancy.123 Overall, there is sparse knowledge on strenuous
strength training in the general pregnant population and no
studies on pregnant elite athletes have been conducted.
Flexibility training
Owing to increased levels of relaxin during pregnancy it has
been stated that pregnant women are more lax and have more
joint instability.124 Neither on the general pregnant population
nor on high level exercisers/elite athletes could we find studies
measuring range of motion during pregnancy. In addition, no
studies were found on the effect of flexibility training during
pregnancy.
Sports to avoid during pregnancy
High-risk sports can be divided into those with risk of trauma
(eg, from a collision or being hit by something (eg, hockey stick)
or falling), and those with physiological risk factors (eg, scuba
diving). In relation to maternal trauma, placental abruption
leading to acute or chronic fetal hypoxia or death, may occur.
Although lots of the available data on this topic have been extra-
polated from pregnant women in motor vehicle accidents,125–127
risks also exist in sports where there may be collision or sudden
deceleration. An exhaustive list cannot be created, but examples
include bobsledding, luge, equestrian (eg, eventing) activities,
pole vaulting, ice hockey and downhill ski racing.5
In relation to physiological risk, pregnant women should
refrain from diving, because the fetus is not protected from
decompression problems and is at risk of malformation and gas
embolism after decompression disease.128 129
Clinical issues in pregnancy with a focus on exercising
women: common complaints and diagnoses—prevention
and treatment options
In this section, we highlight the major symptoms of pregnancy
and explore medical issues, with a special focus on high-level
regular exercisers and elite athletes.
Nausea
Definition
Nausea is a feeling of sickness without actual vomiting.
Retching (or dry heaving, without expulsion of stomach con-
tents) has been described as a distinct symptom that has been
increasingly measured separately to vomiting and nausea.130 131
Morning sickness is a misnomer as it can occur at any time of
the day. Pregnant women experience nausea, vomiting and
retching mostly in the first 6–12 weeks, but in 20% it can con-
tinue up until 20 weeks, or beyond.132 133
Hyperemesis gravidarum is characterised by severe and per-
sistent vomiting, intractable vomiting associated with weight loss
of more than 5% of pre-pregnancy weight, dehydration and
electrolyte imbalance, which may lead to hospitalisation.134 A
detailed expert review on nausea and vomiting was published in
the BMJ by Jarvis and Nelson-Piercy.135
Prevalence
Nausea and vomiting are common in early pregnancy, with
prevalence rates of between 50% and 80% for nausea, and 50%
for vomiting and retching.134 136 Hyperemesis gravidarum is
less common, affecting about 1% of pregnancies.137 No studies
on prevalence among elite athletes were found; however, it is
intuitive that pregnant elite athletes with severe nausea or
vomiting will not be able to train at usual levels.
The exact reasons for nausea, vomiting and retching in preg-
nancy remain unknown, but they are thought to be associated
with rising levels of human chorionic gonadotrophin (HCG) or
oestrogen.138 Conditions with higher levels of HCG (multiple
pregnancies and molar pregnancies) have been associated with
more nausea and vomiting in pregnancy.
Social, physiological and cultural influencing factors have also
been studied.139–141 For example, nausea and vomiting in preg-
nancy may lead to considerable psychosocial stress, through
altered family, social and occupational functioning.142–144 Some
studies have shown that women with a history of eating disor-
ders are more likely to develop nausea and vomiting in
pregnancy.135
Helicobacter pylori seropositivity is also associated with
nausea and vomiting in pregnancy.145 In 105 women exposed to
H. pylori, there was a dose-dependent link between IgG and
severity of hyperemesis gravidarum.146 The clinical implications
of this are yet to be established. In patients who do not respond
to medical therapy, one might consider investigating for
H. pylori as a potentially treatable risk factor.
Differential diagnosis of nausea and vomiting in pregnancy
Hyperemesis gravidarum is a diagnosis of exclusion that requires
systematic history-taking and a thorough clinical assessment.135
The differential diagnosis includes other gastrointestinal path-
ologies including gastritis, appendicitis, cholecystitis and pan-
creatitis. Other pathologies that should be excluded include
urinary tract infections; hyperthyroidism; neurological disorders
(eg, migraine); and ear, nose and throat disease (eg, Meniere’s
disease and vestibular dysfunction).135 Clinicians should be alert
for eating disorders such as bulimia, which is more common in
elite athletes than in non-athletes and may mimic hyperemesis
gravidarum.25
Management of nausea and vomiting in pregnancy
Weight loss, dehydration and electrolyte imbalances are well-
recognised complications of severe nausea and vomiting in preg-
nancy.135 In the most severe cases, fetal growth restriction and
prematurity are also recognised complications.147 148 In rare
instances, Wernicke’s encephalopathy due to vitamin B1 defi-
ciency has been documented.149
In view of the potential complications of severe nausea and
vomiting, early diagnosis and management is important. This is
of particular importance for the elite athlete in training. If a
woman has nausea or vomiting of sufficient severity to affect
fluid and food intake, the clinician should monitor her weight,
examine for signs of dehydration (eg, tachycardia and postural
hypotension), test the urine for ketones and consider assessing
for signs of hypokalaemia, hypercalcaemia, hypocalcaemia
or thyrotoxicosis. Early ultrasonography to identify predispos-
ing factors should be considered (eg, multiple or molar
pregnancy).150
Psychological, non-drug-based and drug-based treatments are
available for women with nausea and vomiting in pregnancy
and hyperemesis gravidarum.135 Dietary support and adequate
fluid intake are central to management. Data suggest that
women with a high intake of fatty foods have a higher risk of
hyperemesis gravidarum and that low-energy high-protein diets
are associated with a reduction of nausea and vomiting in preg-
nancy, compared with a diet high in carbohydrates.151 Women
may also benefit from frequent small meals and separating wet
from dry intake.
A list of possible antiemetics is given below, for when
required. Availability will depend on jurisdiction. Elite athletes
should ensure that any drug management is carried out in asso-
ciation with the Governing Body Medical Officer, to prevent
using substances that are on the WADA list of banned substances
(box 1).
Quality rating: high in the general pregnant population, no
studies on elite athletes.
If pregnant women fail to respond or weight loss becomes
significant, then early admission to the hospital is required for
appropriate management.
Nausea and vomiting during pregnancy are common and dis-
tressing problems that can compromise quality of life, psycho-
logical well-being and performance in elite athletes who
otherwise may be competing at that point in the pregnancy.135
The majority experience significant improvement by the early




Fatigue is ‘an overwhelming sustained sense of exhaustion and
decreased capacity for physical and mental work’.152
Prevalence
Fatigue is a common complaint throughout pregnancy and
during the postpartum period, affecting approximately 90% of
pregnancies.153 Factors that contribute to fatigue include living
environment, support systems, employment status, socio-
economic status, age, number of children, hours of sleep, exer-
cise and lifestyle.152 154 The human body can adapt to fatigue,
but sustained fatigue can lead to alterations in quality of life and
health status.153 No studies were found to evaluate the rate of
fatigue in elite athletes.
Although the majority of fatigue during pregnancy is not
related to a pathological process, it is prudent to exclude severe
anaemia or hypothyroidism in those with persistent symptoms.
Women are considered anaemic in pregnancy if their haemoglo-
bin in the first trimester is <11.0 or <10.5 g/dL after 28 weeks
of gestation.150
Neither in the general pregnant population nor in elite ath-
letes were clinical trials found on the effect of exercise to
reduce fatigue.
Mental health and well-being
Mental health describes both positive psychosocial well-being
and indicators of poor health such as mood disorders, depres-
sion and anxiety. Conditions such as eating disorders (anorexia
nervosa, bulimia, female triad) are not included in this section,
but athletes with these conditions need close follow-up during
pregnancy. Poor maternal mental health is associated with
poorer pregnancy and birth outcomes, and also poses risks for
the offspring later in life.
Box 1 Drugs used commonly in obstetric practice to
treat nausea if indicated. These medications were not on
the WADA list through 31 December 2015, but elite
athletes should always have prescriptions coordinated by
their team clinician.135
▸ Doxylamine 10 mg/pyridoxine 10 mg orally, three times daily
with higher dose at night.
▸ Cyclizine 50 mg orally, intramuscularly or intravenously, three
times daily.
▸ Metoclopramide 10 mg orally, intramuscularly or
intravenously, three times daily.
▸ Prochlorperazine 5 mg orally, 12.5 mg intramuscularly or
intravenously, three times daily; 25 mg rectally, followed if
necessary 6 h later by an oral dose
▸ Promethazine 25 mg orally, at night
▸ Ondansetron 4–8 mg orally, intramuscularly, or by slow
intravenous infusion, two to three times daily
Depression
Depression is a state of low mood and aversion to activity that
can affect a person’s thoughts, behaviour, feelings and sense of
well-being.155 A clinical diagnosis of depression is based on a
diagnostic interview; otherwise the term ‘depressive symptoms’
is used.155
People with depressed mood can feel sad, anxious, empty,
hopeless, helpless, worthless, guilty, irritable, ashamed or rest-
less. They may lose interest in activities that were once pleasur-
able; experience overeating or loss of appetite; have problems
concentrating, remembering details or making decisions; and
may contemplate, attempt or commit suicide. Insomnia, exces-
sive sleeping, fatigue, aches, pains, digestive problems or
reduced energy may also be present.
In the general population, about 6.7% people suffer from
depression in a 12-month period,156 and the prevalence is
higher in young adults. In pregnancy, the average prevalence of
depressive symptoms over seven studies was 22.6%.157 158
Because higher levels of physical activity and exercise are gen-
erally associated with lower risk of depressive symptoms,159 160
it is often presumed that elite athletes will suffer from depres-
sive symptoms less frequently. However, prevalence in elite ath-
letes would suggest no difference in rates of depression from
the general population.161 As in the general population, the
prevalence of depression is higher in female athletes than in
male athletes. Athlete-specific triggers for depression are
injury,162 failure in sport performance163 and involuntary ter-
mination of the athletic career.164 Among athletes, sports gov-
erning bodies and officials, there seems to be a tendency to
downplay or ignore psychiatric problems,165 and athletes tend
to under-report depressive symptoms and rarely seek
help.161 166 167 Whether this tendency persists in pregnancy is
unknown. There are no data on the prevalence of depression
among pregnant athletes.
Several studies have shown that depression during pregnancy is
associated with an increased risk for poor birth outcomes, includ-
ing PTB, LBW, IUGR and pre-eclampsia.168 In a meta-analysis of
results from studies that used a categorical depression measure,
pooled effect sizes were significantly larger (PTB: pooled risk
ratio (RR (95% CI)=1.39 (1.19 to 1.61), LBW: 1.49 (1.25 to
1.77) and IUGR: 1.45 (1.05 to 2.02)) than in studies that used a
continuous depression measure (1.03 (1.00 to 1.06), 1.04 (0.99
to 1.09) and 1.02 (1.00 to 1.04), respectively).169 170 Note that
even with these significant relative risks, the majority of women
with mental health issues have completely normal pregnancy out-
comes. Increased levels of internalising and externalising psycho-
pathology in the children171 as well as difficulties in family
relationships172 have been reported.
Anxiety
Anxiety is an emotion characterised by an unpleasant state of
inner turmoil, often accompanied by nervous behaviour, such
as pacing back and forth, somatic complaints and rumin-
ation.173 Anxiety is not the same as fear, which is a response
to a real or perceived immediate threat, but is the ex-
pectation of future threat.155 Anxiety is often accompanied
by muscular tension, restlessness, fatigue and problems in
concentration.
In the general population in the Netherlands, the 12-month
prevalence of anxiety disorders among women was 12.5% com-
pared with 7.7% in men.174 High levels of anxiety are reported
by around one-quarter of women in the first and second
trimesters of pregnancy.175 However, no consensus exists on
diagnostic instruments or cut points for identifying individuals
with high anxiety levels, so prevalence rates vary between
studies. No data are available for pregnant athletes, and there
are limited data on anxiety in non-pregnant athletes. In
Australia, one study has reported that 12% of female athletes
had high anxiety scores.176
Women may also suffer from specific pregnancy-related
anxiety, such as fear of having a handicapped child, fear of
giving birth, and anxiety about their own changing body and
appearance.177 These pregnancy-related anxieties are not asso-
ciated with general anxiety or depressive feelings,177 and are
reported by 14.4% of pregnant women.178 Fear of giving birth
has been reported by 8% of women in a general pregnant popu-
lation.179 Whether athletes suffer more or less from
pregnancy-related anxieties is unknown, but they might have
anxieties about being able to return to their sporting career, in
the same way as some women have anxiety about returning to
work.180
Prevention and treatment of depression and anxiety during
pregnancy
Pharmaceutical treatment of depressive symptoms with antide-
pressants, such as selective serotonin reuptake inhibitors, is
common in the general population. The decision to use antide-
pressants in pregnancy is based on the mental health needs of
the mother during pregnancy and the postpartum period
balanced against any theoretic concern for the fetus. That being
said, most antidepressants are not contraindicated in preg-
nancy.181 Any medication used by an elite athlete should fit
within the WADA guidelines.182
Cognitive behavioural therapy, an effective preventive and
treatment option for both depression and anxiety outside preg-
nancy,183 184 is also effective in pregnancy and the postpartum
period.185 A 2014 systematic review and meta-analysis found
some evidence to support the effectiveness of exercise in the
prevention and treatment of depression in pregnancy, based on
the findings of six intervention studies of ‘low-moderate’
quality.186 However, these studies were not undertaken in elite
athletes.
Gestational weight gain
Pre-term birth—defined as the amount of weight gained from
conception to delivery—when extreme, may affect the health
and well-being of the mother and infant, 89 187 particularly
in the second and third trimester, GWG is an important
determinant of fetal growth.89 Pregnant women who gain
little weight and who are below IOM recommendations, are
more likely to give birth to a SGAS infant, especially normal
weight and underweight women.187 188 In addition, low
GWG is associated with PTB and failure to initiate breast
feeding.188 189 On the other hand, women who gain above
the recommended amount have increased risk of GDM
and hypertensive disorders, prolonged labour, caesarean
section, macrosomia and large for gestational age infants, as
well as postpartum weight retention and later overweight/
obesity.190–192 Both GWG above and below recommendations
could occur in elite athletes, and may be of concern for preg-
nancy outcomes as well as for return to sport.
Current recommendations for GWG were issued in 200989
and are based on pre-pregnancy BMI categories (table 2).
Women pregnant with twins are given separate
recommendations, ranging from 16.8 to 24.5 kg (37–54 lbs) for
normal weight women, 14.1 to 22.7 kg (31–50 lbs) for over-
weight women and 11.3 to 19.1 kg (25–42 lbs) for obese
women. There are no recommendations specifically for elite
athletes.
Description of GWG
GWG is derived from both maternal and fetoplacental factors,
including increased blood volume (3–4 lbs or 1.4–1.8 kg),
uterus (2 lbs or 0.9 kg), increased extracellular fluid (3–4 lbs or
1.4–1.8 kg), larger breasts (1–2 lbs or 0.4–0.9 kg), fat stores
for breast feeding (5–8 lbs or 2.3–3.6 kg), the baby (7–8 lbs or
3–3.6 kg), placenta (1–1.5 lbs or 0.5–0.7 kg) and amniotic fluid
(2 lbs or 0.9–1 kg).88 89
The rate of weight gain is usually lowest (0.5–2.0 kg in total)
in the first trimester, highest in the second trimester (on average
below 0.50 kg/week) and relatively constant or somewhat
decreasing towards the end of the third trimester.88 89
Adherence to weight gain recommendations
Recent data from the USA show that approximately 15–20% of
women gained below, 26–36% gained within and 42–57% gained
above the IOM recommendations relating to GWG.193–197 Hence,
in a high percentage of pregnant women, weight gain is outside
the current guidelines.
The role of exercise and GWG
In the general obstetric population, observational studies have
shown inconsistent results with respect to relationships between
exercise/physical activity and GWG. Some studies have shown
that a decline in exercise from pre-pregnancy levels was signifi-
cantly related to higher GWG.119 198 Another longitudinal
cohort study showed that women meeting the physical activity
guidelines (≥30 min per day) had 29% (95% CI 0.57% to
0.88%) lower odds of gaining above the IOM recommendations
than did inactive women.199 Stuebe et al200 201 also reported
that mid-pregnancy walking and moderate-intensity exercise, in
accordance with present guidelines, was inversely associated
with the risk of excessive GWG.
Of potential relevance for athletes, studies have shown that
exercise performance influences neither the rate of early preg-
nancy weight gain nor subcutaneous fat deposition (skinfold
thickness), with both decreasing in late pregnancy. Still,
overall pregnancy weight gain was within the normal
range.202–204 Also, higher pre-pregnancy physical activity
levels have been associated with less GWG,205 which is rele-
vant for the athlete. Only one observational study reporting
GWG in elite athletes was found.206 In this retrospective
study of 40 Norwegian elite athletes and age-matched controls
with normal pre-pregnancy BMI, self-reported mean GWG
was lower in the athletes than in the controls (13.9 SD 6.9 kg
vs17.5 SD 9.1 kg, p=0.06).
Prevention and treatment
Several randomised controlled trials (RCTs) have investigated
the effect of exercise on GWG and results differ.8 207–230
However, none of these RCTs included competitive athletes.
Kardel91 investigated the effect of a high-volume and medium-
volume training regime in pregnant elite athletes (n=41), and in
neither fat percentage nor GWG was a significant difference
between the two training groups reported. Studies investigating
the impact of training volume on GWG throughout pregnancy
(early vs late) and the effect on the growing fetus are warranted,
but difficult to conduct. Quality rating: low, no RCTs in elite
athletes. As long as symphysis fundal heights are consistent with
gestational age, more frequent ultrasound assessments are not
required for elite athletes.
Pre-eclampsia
Definition
Pre-eclampsia represents a spectrum of hypertensive disorders
complicated by proteinuria presenting exclusively during preg-
nancy. The spectrum includes those who develop minor ver-
sions of the disorder near term as well as those who develop
severe versions that require significantly premature delivery, the
only known cure for the disorder. In addition to hypertension
and proteinuria, the most severely affected patients may also
develop evidence of end-organ effects manifested by haemoly-
sis, abnormal liver or renal function, clotting disorders, and
thrombocytopaenia. Severe cases may also present with fetal
growth restriction, increasing the risk of stillbirth.231 A detailed
expert review on pre-eclampsia was published by Stocks.232
The level of the quality of the body of evidence for this topic
is moderate.
Prevalence
Pre-eclampsia affects between 2% and 7% of women having
their first child and, of these, 75% will present with signs and
symptoms near term.231 Multiparous women have a lower risk
of pre-eclampsia at 1.7%.233 Compared with Caucasian women,
African, African-American and Latina women have an increased
risk of pre-eclampsia.234 235 The overall rate of pre-eclampsia
has been rising over the past 20 years, due to an increase in two
common risk factors, obesity and diabetes.236 There are no
studies on prevalence of this condition in elite athletes.
Risk factors
The cause and exact mechanisms for pre-eclampsia remain
unclear, but several risk factors have been identified (table 1).
Lack of physical activity should be added to this list. Some of
these risk factors would generally be considered to be less preva-
lent in the elite athlete population than in the general popula-
tion due to their tendency to younger age and low rates of
obesity (box 2).
Box 2 Risk factors for pre-eclampsia
Nulliparity
▸ Pre-eclampsia in a previous pregnancy
▸ Maternal age >40 years
▸ Assisted reproductive technologies
▸ Obesity or excessive weight gain in pregnancy
▸ Mother or sister with history of pre-eclampsia
▸ Maternal low birth weight or premature delivery
▸ Heritable thrombophilias
▸ Chronic hypertension
▸ Type 1 diabetes mellitus
▸ Renal disease
▸ Multifetal gestation
▸ Cocaine or amphetamine use
▸ (references: 231 and 237)
Once pre-eclampsia is diagnosed (box 3), most patients will
undergo investigations to determine whether there have been
associated end-organ effects. The typical investigations include a
blood smear, haemoglobin and haematocrit count, platelet
count, liver transaminases, creatinine, uric acid, and clotting
studies. By performing these investigations, care givers can
exclude the HELLP (haemolysis, elevated liver enzymes, low
platelets) syndrome, one of the most severe versions of pre-
eclampsia. In addition, evaluation of the fetus is required to
assess growth and well-being.
Treatment
There is no specific treatment for pre-eclampsia. Management
will depend on the severity of hypertension, evidence of
end-organ effects, assessments of fetal well-being and, most
importantly, gestational age. Most commonly, induction of
labour will be offered to term patients with mild pre-eclampsia,
whereas, the same patient, when at less than 34 weeks of gesta-
tion, may be placed on antihypertensives and given corticoster-
oids to advance fetal lung maturity, with an attempt to achieve a
greater gestational age at birth. In contrast, despite even a gesta-
tional age <28 weeks, patients with the most severe forms of
pre-eclampsia will require early delivery as there is no other
cure for the rapidly worsening hypertension and end-organ
effects. The most severely affected patients will also be treated
with magnesium sulfate before and after delivery, to prevent the
development of seizures (eclampsia).231 237
Mechanisms through which exercise might reduce the risk of
pre-eclampsia
Weissgerber et al238 proposed four mechanisms by which exer-
cise might reduce the rate of pre-eclampsia. These include
enhanced placental growth and vascularity; prevention and/or
reduction of oxidative stress; reduction of inflammation; and
correction of endothelial dysfunction. Each of these potentially
interactive factors promotes endothelial dysfunction, which
leads to late stage symptoms of pre-eclampsia.236 239 They also
suggest that, for maximum effect on these mechanisms, exercise
should be started in the first trimester.236 238
The role of exercise in preventing pre-eclampsia
Most studies evaluating the effect of exercise on the rate of pre-
eclampsia demonstrate benefit. In their 2014 meta-analysis,233
Wolf et al233 included 11 observational studies evaluating the
impact of leisure time physical activity on the rate of pre-
eclampsia. No RCTs were included. The amount of physical
activity was self-reported in all studies and included leisure
activities such as gardening, walking, running and other aerobic
exercises.
When evaluating the impact of strenuous exercise during
pregnancy on the rate of pre-eclampsia, the studies were incon-
sistent, with four showing a reduction in pre-eclampsia and the
others showing no benefit. One study identified an increased
risk of severe pre-eclampsia in those who exercised more than
270 min/week. None of the studies showed any benefit of light
or moderate leisure time physical activity on the rate of
pre-eclampsia.233
Also, in 2014, Aune et al234 published their systematic review
and meta-analysis of data from 15 cohort and case–control
studies. They reported a 40% reduction in pre-eclampsia for
those women who performed strenuous exercise prior to preg-
nancy, but with no further improvement with durations >5–6 h
of exercise per week. For studies that reported exercise before
24 weeks gestation, they identified a 21% reduction in pre-
eclampsia, with greater benefit in those who exercised at high
intensity (45% reduction) than in those who exercised at low
intensity. Compared with non-exercisers, women who exercised
before and during pregnancy had a 36% reduction in
pre-eclampsia.234
Only one small RCT has evaluated exercise and risk of pre-
eclampsia.240 There was a significantly lower rate of pre-
eclampsia in the stretching exercise group (2.6%, N=38) than
in the walking group (14.6%, N=41). The authors also identi-
fied a significantly higher rate of transferrin, an antioxidant
marker, in the stretching group, and suggested that regular
stretching produces more endogenous antioxidants. Quality
rating: low. No studies have evaluated the effects of exercise on
the rate of pre-eclampsia in elite athletes.
Gestational hypertension
Gestational hypertension is newfound hypertension >140/90
after 20 weeks gestation without proteinuria.231
Prevalence
Approximately 6% of women will develop gestational hyperten-
sion and 25% of these will go on to develop pre-eclampsia,
which is discussed in another section of this document.231 241
There are no studies in elite athletes.
Risk factors
Risk factors for gestational hypertension include nulliparity,
advanced maternal age, obesity, diabetes and renal
disease.242 243
Diagnosis
Gestational hypertension is diagnosed after 20 weeks gestation
in women with no history of hypertension and no proteinuria
when the blood pressure is >140/90 on at least two occasions,
at least 4 h apart.231
Treatment
Treatment of gestational hypertension is dependent on gesta-
tional age. Given the frequency that gestational hypertension
transitions to pre-eclampsia, most women at term will be
offered induction of labour to avoid the possibility of this more
serious hypertensive complication of pregnancy. Women who
are preterm are commonly started on antihypertensive medica-
tions and the frequency of assessments is increased to look for
evidence of pre-eclampsia, or fetal growth restriction.231
Box 3 Diagnosis
Pre-eclampsia is diagnosed by the combination of new
hypertension >140/90 mm Hg and proteinuria after 20 weeks of
gestation. Proteinuria should be suspected when there is a
urinary dipstick of >1+. This should be quantified using either a
24 h urine protein collection of >0.3 g/day, or spot urinary
albumin of >30 mg/mmol of creatinine. Pre-eclampsia is
considered severe if any of the following are present: systolic
blood pressure >160 mm Hg, diastolic blood pressure
>110 mm Hg, severe headache or visual disturbances, right
upper quadrant/epigastric pain, nausea and vomiting,
proteinuria >5 g/day, oliguria <500 mL/24 h, pulmonary oedema
or fetal growth restriction.231 237
The role of exercise in the prevention of gestational hypertension
The large majority of studies evaluating the impact of exercise
on hypertensive complications of pregnancy have used the rate
of pre-eclampsia, rather than the milder gestational hyperten-
sion, as the outcome.
Two epidemiological studies have evaluated the impact of
exercise exposure before and during pregnancy on the rate of
gestational hypertension. One reported a 70% reduction in ges-
tational hypertension among Hispanic women who exercised
before pregnancy; however, the upper confidence limit was
1.0.244 The other found no effect of exercise before or during
pregnancy on the rate of gestational hypertension.245 However,
a recent large RCT showed that women who initiate structured
exercise early in pregnancy are three times more likely to
prevent gestational hypertension, are 1.5 times more likely
to prevent excessive GWG and are 2.5 times more likely to
prevent macrosomic or large babies.246 Quality rating for
prevention: moderate, no studies in elite athletes.
To date, no study has evaluated exercise as a therapy for ges-
tational hypertension (quality rating: very low) and no studies
of gestational hypertension have been conducted with elite
athletes.
Oedema
Oedema refers to the accumulation of excessive watery fluid in
cells, tissues, or serous cavitites. It is very common for pregnant
women to experience dependent oedema, especially during the
third trimester. It is also linked to pre-eclampsia and hyperten-
sion. The physiological explanation for dependent oedema is
related to the substantial increase in blood volume, vessel per-
meability and extracellular fluids, as well as the obstructive pres-
sure of the uterus on the vena cava. There are no published
studies suggesting prenatal exercise as a cause of dependent
oedema.
Hydrotherapy has been suggested as a treatment for depend-
ent oedema by increasing hydrostatic pressure and causing diur-
esis.247 Kent et al248 investigated the impact of hydrotherapy on
dependent oedema. Eighteen healthy women between 20 and
33 weeks were evaluated for 30 min segments standing on land,
standing in water to the axilla and during a low-intensity water
aerobics class with water to the axilla on separate days and in a
random order. Diuresis posttherapy was higher for water aer-
obics (187 mL) and static immersion (180 mL) than for standing
on land (65 mL, p=0.01). Hartmann and Huch249 also showed
that a single session of immersion exercise significantly
decreased the volume and circumference of both legs. Level of
evidence: low. No studies in elite athletes.
Gestational diabetes
Definition
GDM is glucose intolerance with onset or first recognition
during pregnancy.
Prevalence
The prevalence of GDM is increasing, affecting almost 10% of
pregnancies, a reflection of the global obesity epidemic.250 251
Women diagnosed with GDM are at high risk for future dia-
betes, with approximately 50% of women developing type 2
diabetes within 5 years of delivery. It has been estimated that, in
some populations, women with a history of GDM may account
for up to one-third of diabetes cases among parous women.252
Women with GDM represent a heterogeneous group. Some
women have unrecognised pre-existing type 2 diabetes and a
small number have type 1 diabetes, with onset during preg-
nancy; however, the majority are first diagnosed during
pregnancy.250
There are no prevalence studies of GDM among elite athletes.
However, women who are most active before253 254 and during
pregnancy255 are at lower risk of developing GDM.256 257
Pathophysiology
During pregnancy, insulin resistance increases and euglycaemia is
maintained through a compensatory increase in insulin secretion.
GDM appears to be a failure to compensate with increased insulin
secretion. As the increase in insulin resistance is greatest in the third
trimester, GDM usually develops during this time. Therefore,
screening for GDM typically occurs around 24–28 weeks
gestation.258 259
Diagnosis of GDM
There has been much debate about which—universal or select-
ive—screening of pregnant women for GDM is more appropri-
ate. Selective screening for those with the highest risk has been
recommended, especially in low-risk countries. As the preva-
lence of GDM increases, there is a tendency towards universal
screening, as 40% of GDM cases remain undiagnosed using
selective screening.260 261 The fasted oral glucose tolerance test
is the diagnostic test, although criteria vary around the world.
Risk factors for the development of GDM include obesity,
older age, family history, previous history of GDM, or poor
obstetric outcomes, ethnicity, polycystic ovarian syndrome and,
as recently noted, hypertension.250 258 Lack of physical activity
before and during pregnancy may lead to obesity and is an
important risk factor.262–267
GDM is strongly associated with adverse prenatal and post-
natal outcomes, and is related to long-term and short-term mor-
bidity in both the offspring and mother. Adverse infant
outcomes include macrosomia (babies born >4.0 kg), hypogly-
caemia, erythaema, hypocalcaemia, jaundice and birth
trauma.250 268 Later in life, these children are more likely to
become obese, have abnormal glucose tolerance and to develop
diabetes in adolescence or early adulthood. Women with GDM
experience an increased risk of developing pre-eclampsia, infec-
tion and postpartum haemorrhage, and are more likely to
develop overt diabetes, usually type 2, after pregnancy.250 251
Given the risk factors, high-level exercisers and elite athletes
would be expected to have reduced risk for developing
GDM.269 Therefore, we do not review intervention studies in
this report.
Musculoskeletal complaints
Pelvic girdle pain and low back pain
Definition
Pelvic girdle pain (PGP) is pain experienced between the poster-
ior iliac crest and the gluteal fold, particularly in the vicinity of
the sacroiliac joints.270
PGP often arises in relation to pregnancy, with pain related to
the pelvic musculoskeletal system and not from gynaecological
or urological disorders. After the exclusion of lumbar causes,
diagnosis of PGP can be made by reproducing the pain/func-
tional impairments related to PGP, using specific clinical tests.270
Although similar and overlapping features may be ascribed to
low back pain (LBP) and to PGP, during pregnancy, PGP appears
to have more impact on disability than does LBP.38 270–273 PGP
disorders have a characteristic clinical presentation, and with
this comes a need for specific management.273–275
Pregnancy-related LBP and PGP are common in many countries,
regardless of socioeconomic factors,276–278 and have a negative
effect on daily activities, exercise and training.279
Prevalence
The prevalence rate of pregnancy-related LBP and PGP is
estimated to be about 50% during pregnancy.280 An estimated
20–25% of all pregnant women suffer from PGP sufficiently ser-
iously to require medical help.270 280 Only one study has inves-
tigated PGP and LBP in elite athletes, reporting a prevalence of
29.6% for PGP and 18.5% for LBP during pregnancy, similar to
non-athletic controls.206 Previous LBP, previous LBP and/or PGP
during or after pregnancy, strenuous work and previous trauma
to the pelvis, are commonly identified risk factors.270 280
Aetiology and pathogenesis
The aetiology and pathogenesis of PGP is uncertain and prob-
ably multifactorial. The pelvis transfers load from the trunk to
the legs and this requires a stable pelvis. Overload of the liga-
ments of the pelvis may be a result of impaired load transfer
during activities and hence have an influence on PGP.281–283
The sacrospinous and the long dorsal sacroiliac ligament are
both thought to be a possible source of pain in PGP.284–288 The
changes in spinal curvature during pregnancy as well as frequent
or sustained pain-provoking postures might influence the pelvic
ligaments, causing pain. It is probably important that elite ath-
letes are aware of their body positions while pregnant to avoid
unnecessary load and stress on joint, ligaments and muscles,
during exercise and daily activities.
Treatment and prevention
Twenty-six RCTs that examined the effects of a variety of inter-
ventions for LBP and PGP during pregnancy were included in
an updated Cochrane review.289 Based on evidence of moderate
quality, this review suggests that different types of exercise and
acupuncture significantly reduce evening PGP or lumbopelvic
pain more than normal care alone. According to the European
guideline for PGP, individualised exercises to treat PGP in preg-
nancy are recommended.270
There is limited knowledge on how to prevent LBP and PGP
in pregnancy,289 with lack of evidence of a positive effect of
group training,290–293 and inconsistent findings on whether
regular physical activity before pregnancy can reduce the risk of
LBP and/or PGP during pregnancy.294 295 Women who reported
high-impact exercise 3–5 times per week before pregnancy had
a 14% lower risk of developing severe PGP in pregnancy com-
pared with non-exercisers.296 In a longitudinal cohort study, a
greater loss of physical condition seems not to be a cause but
rather a consequence of LBP and/or PGP in pregnancy,297 hence
knowledge about type of exercise and dose is needed. Quality
rating: moderate. No studies on prevention or treatment of LBP
and PGP in pregnant elite athletes were identified.
Pelvic floor dysfunction
Definitions
Pelvic floor dysfunction (PFD) is defined as the presence of
symptoms of UI or AI, POP, sensory or emptying abnormalities
of the lower urinary tract, defaecation dysfunction, sexual dys-
function and pelvic floor pain syndromes. The conditions can
present separately or coexist.298 UI is defined as a complaint of
involuntary passing of urine.299 The most prevalent form of
female PFD is stress UI (SUI)—‘the complaint of involuntary
leakage on effort or exertion (eg, sporting activities), or on
sneezing or coughing’.299 Urgency UI (UUI) is the complaint of
involuntary passing of urine associated with urgency.299 AI is
‘involuntary passing of faeces or flatus’, while faecal incontin-
ence is limited to involuntary passing of faeces (solid or
liquid).299 The definition of anatomical POP is ‘the descent of
one or more of the anterior vaginal wall, posterior vaginal wall,
the uterus (cervix), or the apex of the vagina (vaginal vault or
cuff scar after hysterectomy)’.299 The presence of any such sign
should be correlated with relevant POP symptoms. POP ranges
from asymptomatic minor changes in vaginal support, common
after childbirth, to severe vaginal bulging for which women
choose treatment.
Prevalence
The prevalence of UI in nulliparous women and in female elite
athletes is high.300 301 Prevalence rates range between 28% and
80% during sporting activities in female elite athletes.301 UI
occurs most commonly in sports involving high-impact activities
such as trampolining and gymnastics. While athletes report that
they feel embarrassed about the condition and that it may affect
performance, in one study, 84% had never spoken with their
coaches or healthcare providers about UI.302 In a retrospective
study on Norwegian elite athletes who had given birth, 12.9%
reported SUI the year before the birth and 18.5% during preg-
nancy. These rates of prevalence did not differ from those in a
matched control group.206
AI affects one in four primiparous women during the third
trimester.303 304 In one study, the prevalence of AI, generally
limited to flatus incontinence, was higher in women (aged
18–40 years) who exercised more than 8 h/week (14.8%) than
in a comparison group (4.9%, p=0.001).305 In the retrospective
study of elite athletes, none recalled AI during pregnancy or
after childbirth.206
Among 116 nulliparous female US Military Academy cadets,
those who attended paratrooper training were significantly more
likely to demonstrate stage II POP on examination after 6 weeks
than those who did not (RR=2.72, 1.37<RR<5.40;
p=0.003).306
No prospective studies of POP in elite female athletes (preg-
nant or non-pregnant) were found.
Aetiology and risk factors for PFDs
Risk factors for PFDs include pregnancy and childbirth-related
factors (injuries to peripheral nerves, connective tissue and
muscles), heritage and ethnicity, obesity, behavioural factors,
ageing, and strenuous work. Vaginal birth is the strongest risk
factor for POP in women of all ages, while vaginal birth
increases the risk for UI by about two-fold in younger and
middle-aged women, but no longer plays a role in older
women.123 300 307
DeLancey et al308 presented an integrated life span model of
causal factors of PFD. Phase I comprises predisposing factors,
which include genetic construction, nutritional factors and
socialisation. Phase II comprises inciting factors, which include
predisposing maternal–fetal factors such as pelvic floor shape
and size, macrosomic infant, fetal head position, effects of
obstetric interventions such as use of forceps, prolonged second
stage and occipit posterior position, all leading to potential
injury (muscle, connective tissue and nerve avulsion/compres-
sion). Phase III comprises intervening factors, which include
variation in normal ageing of muscles, nerves and connective
tissue; increased stress to the pelvic floor (occupational lifting,
strenuous activity, obesity or chronic cough); and factors leading
to weakening of the support tissues (chronic steroid use or
disuse atrophy of muscles).
Aetiology and risk factors for UI in elite athletes
Bø et al301 found that women exercising ≥3 times per week at
gestational week 37 had a significantly larger levator hiatus area
than did non-exercising women. However, these women were
not elite athletes. In a study of college athletes, Nygaard et al309
found no significant association between UI and amenorrhoea,
weight, hormonal therapy or duration of athletic activity. In a
study of former US Olympians, among factors such as age, BMI,
parity, Olympic sport group and incontinence during Olympic
sport 20 years ago, only current BMI was significantly associated
with regular SUI or urgency incontinence symptoms.310 Bø and
Sundgot-Borgen311 reported that significantly more elite athletes
with eating disorders had symptoms of both SUI and UUI.
Eliasson et al312 showed that incontinent trampolinists were sig-
nificantly older (16 vs 13 years), had been training longer and
more frequently, and were less able to interrupt the urine flow
stream by voluntarily contracting the pelvic floor muscle, than
the non-leaking group.
Prevention and treatment
Devices that involve external urinary collection, intravaginal
support of the bladder neck or blockage of urinary leakage by
occlusion are available,313 and some have reportedly been
effective in preventing leakage during physical activity.314 For
smaller leakage, specially designed protecting pads can be used
during training and competition. No RCTs have evaluated the
effect of preventive devices in elite athletes.
According to the most recent Cochrane review, in the general
population, pregnant women without UI randomly assigned to
intensive antenatal pelvic floor muscle training were less likely to
report UI up to 6 months after delivery than were controls who
received usual care (about 30% less; RR 0.71, 95% CI 0.54 to
0.95, combined result of five trials).315 As several studies have
found that >30% of women are not able to perform a correct
PFM contraction at their first consultation, thorough instruction
of how to perform a contraction and assessment of ability to con-
tract is vital.316 In studies with favourable results, the women
have performed supervised PFM training in combination with
home exercise.315
Prevention/treatment
No studies were found on prevention or treatment strategies for
diastasis recti abdominis during pregnancy, either in the general
pregnant population or in elite athletes. Quality rating: high in
the general population. There are no studies of interventions to
prevent or reduce PFD during pregnancy in female elite athletes.
Diastasis recti abdominis
Definition
Diastasis recti abdominis (DRA) is an impairment with midline
separation of the two rectus abdominis muscles along the linea
alba.317
Prevalence
Prevalence rates (with and without protrusion/hernia) during
pregnancy vary between 27% and 100% in the second and
third trimester.318 319 There are no prevalence studies among
elite athletes during pregnancy.
DRA is diagnosed by measuring the distance between the
median borders of rectus abdominis (inter-rectus distance);
measurement methods in use are palpation with fingerbreadths,
caliper or ultrasound.320 To date, there is no consensus on
where to measure the distance along the linea alba, or on the
cut-point for diagnosing the condition.319
Aetiology and risk factors
The aetiology of DRA is not clear. While some believe that
DRA affects abdominal muscle strength or spinal stability during
pregnancy, we identified no data on DRA and LBP or PGP
during pregnancy, and found no studies testing the theory that
DRA can be prevented or treated with abdominal or other exer-
cises during pregnancy. A recently published systematic review
concluded that there is an urgent need for more research on the
prevalence, risk factors, prevention and treatment of the condi-
tion.321 Female athletes usually train the abdominals regularly
and anecdotally have stronger abdominal muscles than the
general population. Whether this is a protective factor or a risk
factor for development of DRA in pregnancy is not known.
Quality rating: very low. There is no evidence to guide elite ath-
letes on abdominal training during pregnancy.
Other parts in the 5-part series
In addition to this Part 1, four other parts of IOC expert group
meeting will be published in future issues of BJSM.
Part 2: Effect of having exercised (physical fitness) on labour
and neonatal/fetal outcomes.
Part 3: Guidance on returning to exercise in the the postpartum
period.
Part 4: Research directions.
Part 5: Recommendations for health professionals and active
women.
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